4.2 Article

Expansion of breast cancer stem cells with fibrous scaffolds

期刊

INTEGRATIVE BIOLOGY
卷 5, 期 5, 页码 768-777

出版社

OXFORD UNIV PRESS
DOI: 10.1039/c3ib20255k

关键词

-

资金

  1. NIH [3P20RR017698-08]
  2. American Cancer Society Research Award [RSG-10-067-01-TBE]
  3. US NSF [CHE-0748690]
  4. Camille Dreyfus Teacher Scholar Award
  5. Direct For Mathematical & Physical Scien
  6. Division Of Chemistry [0748690] Funding Source: National Science Foundation
  7. Direct For Mathematical & Physical Scien
  8. Division Of Mathematical Sciences [1019544] Funding Source: National Science Foundation

向作者/读者索取更多资源

Cancer stem cells (CSCs) are hypothesized as tumor-initiating cells within tumors and main contributors of tumor growth, metastasis and recurrence. Mammary cancer cells, MCF-7 cells, were cultured on 3D polycaprolactone (PCL) fibrous scaffolds, showing an increased proportion of CSCs. The expression of stem cell markers, including OCT3/4 and SOX2, and breast CSC-specific markers, SOX4 and CD49f, was significantly upregulated, and the mammosphere-forming capability in cells cultured on PCL fibrous scaffolds increased. The fibrous scaffolds also induced the elongation of MCF-7 cells and extended cell proliferation. The increase of CSC properties after being cultured on fibrous scaffolds was further confirmed with two luminal-type mammary cell lines, T47D and SK-BR-3, and a basal-type cell line, MDA-MB-231, by ALDEFLUOR assay and mammosphere formation assay. Moreover, we observed the upregulation of epithelial to mesenchymal transition and increased invasive capability in cells cultured on PCL fibrous scaffolds. These data suggest that the increase of CSC proportion in a 3D culture system may account for the enhanced malignancy. Therefore, our PCL fibrous scaffolds can potentially be used for CSCs enrichment and anti-cancer drug screening.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据